TetraLogic Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2012 | -15.92M | 5.49M | 4.93M |
|---|---|---|---|
| 2013 | -12.76M | -67.31K | 63.45M |
| 2014 | -32.36M | -53.97M | 44.34M |
| 2015 | -34.88M | 35.44M | 1.79M |
| 2019 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 |
TLOG Cash Flow Statement (2012 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | 0 | 0 | 13.07M | 55.13M | 4.51M | 10.00M |
Operating activities | ||||||||
Net income | 0 | 0 | 0 | 0 | -49.72M | -35.95M | 0 | -16.19M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 187.99K | 125.95K | 99.59K | 154.02K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 5.68M | 3.38M | 3.70M | 350.94K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 5.68M | 3.38M | 3.70M | 350.94K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 0 | 0 | 0 | 0 | -34.88M | -32.36M | -12.76M | -15.92M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -24.41M | -66.29M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | -77.33K | -514.85K | -67.31K | -28.93K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -12.84M | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 35.44M | -53.97M | -67.31K | 5.49M |
Financing activities | ||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 2.61M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -825.00K | -44.14K | 0 | -33.96K |
Cash used in financing activities | 0 | 0 | 0 | 0 | 1.79M | 44.34M | 63.45M | 4.93M |
Net Change In Cash | 0 | 0 | 0 | 0 | 2.22M | -42.06M | 50.62M | -5.49M |
Cash at end of period | 0 | 0 | 0 | 0 | 15.30M | 13.07M | 55.13M | 4.51M |